Transcatheter Aortic Valve Implantation in Sievers Type 0 vs. Type 1 Bicuspid Aortic Valve Morphology: Systematic Review and Meta-Analysis

Background: Transcatheter aortic valve implantation (TAVI) has achieved satisfactory outcomes in the selected patients with bicuspid aortic valve (BAV), predominately type 1 BAV (~90%). However, there are few reports about the safety and efficacy of TAVI in type 0 BAV. Therefore, in the current stud...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yu Du, Zhijian Wang, Wei Liu, Yonghe Guo, Wei Han, Hua Shen, Shuo Jia, Yi Yu, Kangning Han, Dongmei Shi, Yingxin Zhao, Yujie Zhou
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/08b42f55c9ee44b59917fdec3d72d293
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:08b42f55c9ee44b59917fdec3d72d293
record_format dspace
spelling oai:doaj.org-article:08b42f55c9ee44b59917fdec3d72d2932021-11-05T10:13:06ZTranscatheter Aortic Valve Implantation in Sievers Type 0 vs. Type 1 Bicuspid Aortic Valve Morphology: Systematic Review and Meta-Analysis2297-055X10.3389/fcvm.2021.771789https://doaj.org/article/08b42f55c9ee44b59917fdec3d72d2932021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcvm.2021.771789/fullhttps://doaj.org/toc/2297-055XBackground: Transcatheter aortic valve implantation (TAVI) has achieved satisfactory outcomes in the selected patients with bicuspid aortic valve (BAV), predominately type 1 BAV (~90%). However, there are few reports about the safety and efficacy of TAVI in type 0 BAV. Therefore, in the current study, we aimed to compare procedural and 30-day outcomes after TAVI between type 0 and type 1 BAV.Methods: Studies comparing the outcomes of TAVI in Sievers type 0 vs. type 1 BAV were retrieved from PubMed, EMBASE, Cochrane Library, and Web of Science from inception to May 2021. The data were extracted regarding the study characteristics and outcomes. The odds ratios (ORs) with 95% CIs were pooled for procedural and 30-day outcomes.Results: Six observational studies were included with determined type 0 BAV in 226 patients and type 1 BAV in 902 patients. The patients with type 0 BAV were slightly younger, had larger supra-annular structure, and more frequently implanted self-expanding prosthesis compared with type 1 BAV. In the pooled analyses, the patients with type 0 BAV had a similar incidence of procedural death (OR = 2.6, 95% CI 0.7–10.3), device success (OR = 0.6; 95% CI 0.3–1.3), and ≥ mild (OR = 0.8; 95% CI 0.4–1.6) or moderate (OR = 0.9, 95% CI 0.4–1.8) paravalvular leak, whereas significantly higher mean aortic gradient (mean difference = 1.4 mmHg, 95% CI 0.03–2.7) and increased coronary compromise risk (OR = 7.2; 95% CI 1.5–34.9), compared with type 1 BAV. Meanwhile, the incidence of death (OR = 1.2; 95% CI 0.5–3.1), stroke (OR = 0.5; 95% CI 0.1–2.4), and new pacemaker (OR = 0.6; 95% CI 0.2–2.2) at 30 days were not significantly different between the BAV morphologies (p > 0.05). The treatment effect heterogeneity across the studies for the above outcomes were low.Conclusions: The patients with type 0 BAV appear to have similar short-term outcomes after TAVI compared with type 1 BAV. Whereas, TAVI for type 0 BAV aortic stenosis might lead to an elevated coronary obstruction risk and suboptimal aortic valvular hemodynamics.Yu DuZhijian WangWei LiuYonghe GuoWei HanHua ShenShuo JiaYi YuKangning HanDongmei ShiYingxin ZhaoYujie ZhouFrontiers Media S.A.articletranscatheter aortic valve implantationSievers type 0outcomesmeta-analysisbicuspid aortic valveDiseases of the circulatory (Cardiovascular) systemRC666-701ENFrontiers in Cardiovascular Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic transcatheter aortic valve implantation
Sievers type 0
outcomes
meta-analysis
bicuspid aortic valve
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle transcatheter aortic valve implantation
Sievers type 0
outcomes
meta-analysis
bicuspid aortic valve
Diseases of the circulatory (Cardiovascular) system
RC666-701
Yu Du
Zhijian Wang
Wei Liu
Yonghe Guo
Wei Han
Hua Shen
Shuo Jia
Yi Yu
Kangning Han
Dongmei Shi
Yingxin Zhao
Yujie Zhou
Transcatheter Aortic Valve Implantation in Sievers Type 0 vs. Type 1 Bicuspid Aortic Valve Morphology: Systematic Review and Meta-Analysis
description Background: Transcatheter aortic valve implantation (TAVI) has achieved satisfactory outcomes in the selected patients with bicuspid aortic valve (BAV), predominately type 1 BAV (~90%). However, there are few reports about the safety and efficacy of TAVI in type 0 BAV. Therefore, in the current study, we aimed to compare procedural and 30-day outcomes after TAVI between type 0 and type 1 BAV.Methods: Studies comparing the outcomes of TAVI in Sievers type 0 vs. type 1 BAV were retrieved from PubMed, EMBASE, Cochrane Library, and Web of Science from inception to May 2021. The data were extracted regarding the study characteristics and outcomes. The odds ratios (ORs) with 95% CIs were pooled for procedural and 30-day outcomes.Results: Six observational studies were included with determined type 0 BAV in 226 patients and type 1 BAV in 902 patients. The patients with type 0 BAV were slightly younger, had larger supra-annular structure, and more frequently implanted self-expanding prosthesis compared with type 1 BAV. In the pooled analyses, the patients with type 0 BAV had a similar incidence of procedural death (OR = 2.6, 95% CI 0.7–10.3), device success (OR = 0.6; 95% CI 0.3–1.3), and ≥ mild (OR = 0.8; 95% CI 0.4–1.6) or moderate (OR = 0.9, 95% CI 0.4–1.8) paravalvular leak, whereas significantly higher mean aortic gradient (mean difference = 1.4 mmHg, 95% CI 0.03–2.7) and increased coronary compromise risk (OR = 7.2; 95% CI 1.5–34.9), compared with type 1 BAV. Meanwhile, the incidence of death (OR = 1.2; 95% CI 0.5–3.1), stroke (OR = 0.5; 95% CI 0.1–2.4), and new pacemaker (OR = 0.6; 95% CI 0.2–2.2) at 30 days were not significantly different between the BAV morphologies (p > 0.05). The treatment effect heterogeneity across the studies for the above outcomes were low.Conclusions: The patients with type 0 BAV appear to have similar short-term outcomes after TAVI compared with type 1 BAV. Whereas, TAVI for type 0 BAV aortic stenosis might lead to an elevated coronary obstruction risk and suboptimal aortic valvular hemodynamics.
format article
author Yu Du
Zhijian Wang
Wei Liu
Yonghe Guo
Wei Han
Hua Shen
Shuo Jia
Yi Yu
Kangning Han
Dongmei Shi
Yingxin Zhao
Yujie Zhou
author_facet Yu Du
Zhijian Wang
Wei Liu
Yonghe Guo
Wei Han
Hua Shen
Shuo Jia
Yi Yu
Kangning Han
Dongmei Shi
Yingxin Zhao
Yujie Zhou
author_sort Yu Du
title Transcatheter Aortic Valve Implantation in Sievers Type 0 vs. Type 1 Bicuspid Aortic Valve Morphology: Systematic Review and Meta-Analysis
title_short Transcatheter Aortic Valve Implantation in Sievers Type 0 vs. Type 1 Bicuspid Aortic Valve Morphology: Systematic Review and Meta-Analysis
title_full Transcatheter Aortic Valve Implantation in Sievers Type 0 vs. Type 1 Bicuspid Aortic Valve Morphology: Systematic Review and Meta-Analysis
title_fullStr Transcatheter Aortic Valve Implantation in Sievers Type 0 vs. Type 1 Bicuspid Aortic Valve Morphology: Systematic Review and Meta-Analysis
title_full_unstemmed Transcatheter Aortic Valve Implantation in Sievers Type 0 vs. Type 1 Bicuspid Aortic Valve Morphology: Systematic Review and Meta-Analysis
title_sort transcatheter aortic valve implantation in sievers type 0 vs. type 1 bicuspid aortic valve morphology: systematic review and meta-analysis
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/08b42f55c9ee44b59917fdec3d72d293
work_keys_str_mv AT yudu transcatheteraorticvalveimplantationinsieverstype0vstype1bicuspidaorticvalvemorphologysystematicreviewandmetaanalysis
AT zhijianwang transcatheteraorticvalveimplantationinsieverstype0vstype1bicuspidaorticvalvemorphologysystematicreviewandmetaanalysis
AT weiliu transcatheteraorticvalveimplantationinsieverstype0vstype1bicuspidaorticvalvemorphologysystematicreviewandmetaanalysis
AT yongheguo transcatheteraorticvalveimplantationinsieverstype0vstype1bicuspidaorticvalvemorphologysystematicreviewandmetaanalysis
AT weihan transcatheteraorticvalveimplantationinsieverstype0vstype1bicuspidaorticvalvemorphologysystematicreviewandmetaanalysis
AT huashen transcatheteraorticvalveimplantationinsieverstype0vstype1bicuspidaorticvalvemorphologysystematicreviewandmetaanalysis
AT shuojia transcatheteraorticvalveimplantationinsieverstype0vstype1bicuspidaorticvalvemorphologysystematicreviewandmetaanalysis
AT yiyu transcatheteraorticvalveimplantationinsieverstype0vstype1bicuspidaorticvalvemorphologysystematicreviewandmetaanalysis
AT kangninghan transcatheteraorticvalveimplantationinsieverstype0vstype1bicuspidaorticvalvemorphologysystematicreviewandmetaanalysis
AT dongmeishi transcatheteraorticvalveimplantationinsieverstype0vstype1bicuspidaorticvalvemorphologysystematicreviewandmetaanalysis
AT yingxinzhao transcatheteraorticvalveimplantationinsieverstype0vstype1bicuspidaorticvalvemorphologysystematicreviewandmetaanalysis
AT yujiezhou transcatheteraorticvalveimplantationinsieverstype0vstype1bicuspidaorticvalvemorphologysystematicreviewandmetaanalysis
_version_ 1718444268208521216